Ahmed Nader

Identification of HLA-DRB1 association to adalimumab immunogenicity

Mohan Liu, Jacob F. Degner, J. Wade Davis et al. · PLoS ONE · 2018 · 66 citations · Full text

Clinical and Pharmacokinetic Outcomes of Peak–Trough-Based Versus Trough-Based Vancomycin Therapeutic Drug Monitoring Approaches: A Pragmatic Randomized Controlled Trial

Fatima Khalifa Al‐Sulaiti, Ahmed Nader, Mohamed Saad et al. · European Journal of Drug Metabolism and Pharmacokinetics · 2019 · 45 citations · Full text

Impact of immunogenicity on pharmacokinetics, efficacy and safety of adalimumab in adult patients with moderate to severe chronic plaque psoriasis

Nael M. Mostafa, Ahmed Nader, Peter Noertersheuser et al. · Journal of the European Academy of Dermatology and Venereology · 2016 · 43 citations

Pharmacokinetics of Upadacitinib in Healthy Subjects and Subjects With Rheumatoid Arthritis, Crohn's Disease, Ulcerative Colitis, or Atopic Dermatitis: Population Analyses of Phase 1 and 2 Clinical Trials

Ahmed Nader, Sven Stodtmann, Anna Friedel et al. · The Journal of Clinical Pharmacology · 2019 · 40 citations

Population Pharmacokinetics of Intravenous Methotrexate in Patients with Hematological Malignancies: Utilization of Routine Clinical Monitoring Parameters

Ahmed Nader, Noran Zahran, Aya Alshammaa et al. · European Journal of Drug Metabolism and Pharmacokinetics · 2016 · 36 citations

Hematological Malignancy, Therapeutic Drug Monitoring, Oncology +9